CCW16
Based on 1 Customer Validation
CCW16 is a non-selective cysteine-reactive covalent ligand and an RNF4 E3 ubiquitin ligase recruiter with an IC50 of 1.8 μM against human RNF4[. CCW16 covalently modifies accessible cysteine residues on RNF4, PRDX1, PRDX2, and PRDX6, attenuating the peroxide-scavenging activity of peroxiredoxins. CCW16 induces oxidative stress through upregulation of HMOX1 and NRF2, and triggers ferroptosis via lipid peroxidation and ROS signaling pathways in an RNF4-independent manner. CCW16 serves as an RNF4-recruiting moiety; it does not induce RNF4 degradation when used alone and can be used to synthesize protein degraders, such as the PROTAC compound CCW 28-3 (HY-156774). CCW16 can be used for research on acute myeloid leukemia and hepatocellular carcinoma.
For research use only. We do not sell to patients.
- Purity : 98.73%
- CAS No.: 2361138-33-0
- Formula: C22H20ClNO3
- Molecular Weight:381.85
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Biological Activity
Description
IC50 & Target
[4]|
RNF4 1.8 μM (IC50) |
In Vitro
CCW16 (5 μM; 6 h) in HeLa Flp-In T-REx cells with inducible RNF4 does not degrade RNF4 but induces upregulation of HMOX1, heat shock protein 70 family members, and NRF2, consistent with an oxidative stress response[1].
CCW16 (5 μM; 6 h)-induced upregulation of HMOX1 and NRF2 occurs in both wild-type and RNF4 knockout HeLa cells, confirming that the oxidative stress response is RNF4-independent[1].
CCW16 (6 h) alone does not degrade RNF4 protein in HepG2 cells[3].
CCW16 (10 μM; 2 h + overnight) in HeLa cell lysates reacts non-selectively with approximately 1200 proteins, including the catalytic cysteines of peroxiredoxins PRDX1, PRDX2, and PRDX6, identifying CCW16 as a non-selective covalent ligand that disrupts redox homeostasis[1].
CCW16 (2.5 μM; 2.5 h) induces robust lipid peroxidation in OCI-AML2 cells within 2.5 h, a key hallmark of ferroptosis[1].
CCW16 (1 μM; 6 h) reduces viability of OCI-AML2 cells after 6 h via induction of ferroptosis, which is rescued by the ferroptosis inhibitor Ferrostatin-1 (HY-100579)[1].
CCW16 (5 μM; 6 h)-induced ferroptotic cell death in HT-1080 cells is fully rescued by GPX4 overexpression, demonstrating that CCW16 exerts its ferroptotic effect through a GPX4-sensitive pathway[1].
CCW16 (10 µM; 2 h at 4 °C plus overnight at 4 °C) covalently modifies a broad spectrum of over 2000 proteins, including the catalytic cysteines of peroxiredoxins PRDX1, PRDX2, and PRDX6, indicating low target selectivity[2].
CCW16 binds covalently to RNF4 at C132 or C135 with a low micromolar affinity of 1.8 μM but does not inhibit RNF4 enzymatic activity[3].
CCW 16 covalently inhibits RNF4 with an IC50 of 1.8 μM by modifying zinc-coordinating cysteines C132 and C135 in the RING domain[4].
CCW16 (5 µM; 6 h) does not degrade RNF4 but induces a strong RNF4-independent oxidative stress response marked by upregulation of HMOX1, NRF2, and heat shock proteins, with enrichment of the ferroptosis pathway[2].
CCW16 (2.5 µM; 2.5 h) induces robust lipid peroxidation in OCI-AML2 cells[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Wild-type and RNF4 knockout HeLa cells
-
Concentration:5 μM
-
Incubation Time:6 h
-
Result:Induced upregulation of HMOX1 in both wild-type and RNF4 knockout HeLa cells, demonstrating the stress response is independent of RNF4.
Increased NRF2 protein levels in both wild-type and RNF4 knockout HeLa cells, consistent with activation of the NRF2-mediated oxidative stress response pathway.
-
Cell Line:OCI-AML2 acute myeloid leukemia cells
-
Concentration:1 μM
-
Incubation Time:6 h; 1 h (ferrostatin-1 pretreatment)
-
Result:Caused a significant reduction in OCI-AML2 cell viability.
Induced cell death that was substantially rescued by pretreatment with the ferroptosis inhibitor ferrostatin-1, confirming cell death occurs via ferroptosis.
-
Cell Line:HT-1080 fibrosarcoma cells
-
Concentration:5 μM
-
Incubation Time:6 h; 1 h (ferrostatin-1 pretreatment)
-
Result:Induced cell death in parental HT-1080 cells carrying an empty vector.
Did not induce cell death in cells stably overexpressing GPX4, which were fully protected, indicating ferroptotic activity is linked to GPX4 function.
Chemical Information
-
CAS No. 2361138-33-0
-
Appearance Solid
-
Molecular Weight 381.85
-
Formula C22H20ClNO3
-
Color Light yellow to yellow
-
SMILES
O=C(N(CC1=CC=CC=C1)C2=CC=C(OC3=CC=C(OC)C=C3)C=C2)CCl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Solvent & Solubility
In Vitro:
DMSO : 25 mg/mL (65.47 mM; ultrasonic and warming and heat to 60°C; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
Purity & Documentation
-
Data Sheet (283 KB)
-
SDS (458 KB)
- English - EN (458 KB)
- Français - FR (458 KB)
- Deutsch - DE (458 KB)
- Norwegian - NO (458 KB)
- Español - ES (458 KB)
- Swedish - SV (458 KB)
- Italian - IT (458 KB)
- Korean - KR (458 KB)
- Portuguese - PT (458 KB)
-
Handling Instructions (2659 KB)
References
[3]. Wan H, et al. Development of the first-in-class RNF4 PROTAC degrader as potential therapeutics for hepatocellular carcinoma. European journal of medicinal chemistry. 2026 Apr 05;307:118668. [Content Brief]
[4]. Kiely-Collins H, et al. The role of reversible and irreversible covalent chemistry in targeted protein degradation. Cell Chem Biol. 2021 Jul 15;28(7):952-968. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.6188 mL | 13.0941 mL | 26.1883 mL | 65.4707 mL |
| 5 mM | 0.5238 mL | 2.6188 mL | 5.2377 mL | 13.0941 mL | |
| 10 mM | 0.2619 mL | 1.3094 mL | 2.6188 mL | 6.5471 mL | |
| 15 mM | 0.1746 mL | 0.8729 mL | 1.7459 mL | 4.3647 mL | |
| 20 mM | 0.1309 mL | 0.6547 mL | 1.3094 mL | 3.2735 mL | |
| 25 mM | 0.1048 mL | 0.5238 mL | 1.0475 mL | 2.6188 mL | |
| 30 mM | 0.0873 mL | 0.4365 mL | 0.8729 mL | 2.1824 mL | |
| 40 mM | 0.0655 mL | 0.3274 mL | 0.6547 mL | 1.6368 mL | |
| 50 mM | 0.0524 mL | 0.2619 mL | 0.5238 mL | 1.3094 mL | |
| 60 mM | 0.0436 mL | 0.2182 mL | 0.4365 mL | 1.0912 mL |